
A potent vinca alkaloid derived from the periwinkle plant. Primarily used as a chemotherapy medication for treating various types of cancer, including Hodgkin’s disease and non-small cell lung cancer.
Cytotoxic purity is the most vital factor in chemotherapy production. For this reason, the molecular integrity of our vinca alkaloids defines the safety of oncological treatments. Zyntex Vinblastine sulfate is an excellent choice for treating aggressive malignancies. For instance, it is a primary component in protocols for Hodgkin’s lymphoma. In addition, it acts by inhibiting mitosis through binding to tubulin. Consequently, we maintain a highly controlled cold-chain process to prevent degradation. This ensures the product remains potent during formulation. As a result, this ingredient delivers consistent clinical outcomes for healthcare providers worldwide.
Zyntex supplies Vinblastine sulfate in a sterile crystalline powder form. This form is designed for rapid solubility in injectable solutions. Thus, it fits perfectly into the manufacturing of intravenous chemotherapy vials. Furthermore, it is ideal for advanced clinical research regarding cell cycle arrest. Our quality control measures ensure a negligible level of residual solvents. Because of this, the product offers superior safety profiles for patient administration. Moreover, it features an excellent stability profile under recommended cryogenic conditions. Since it is light-sensitive, we utilize specialized protective packaging. Therefore, you can rely on the chemical’s structural purity upon arrival.
This versatile oncology agent is a staple for the global pharmaceutical R&D sectors. Specifically, it supports the development of combination therapies for various cancers. Its consistent chemical profile means it does not interact negatively with other agents. Also, it helps maintain the strict potency requirements of health authorities. Consequently, Zyntex provides a dependable foundation for your life-science innovation. We support both large-scale manufacturers and innovative biotech research. For more detailed chemical data, you can visit the PubChem Vinblastine Database. Finally, our commitment to quality helps your brand achieve international regulatory approval effortlessly.
It acts as a primary active ingredient. Specifically, it is used in intravenous treatments for managing Hodgkin’s disease and other lymphomas.
This is an essential tool for studying microtubule inhibition. Therefore, it is vital for advanced drug development and cellular studies.
It works as a high-purity API for sterile filling. Consequently, it is used in the production of high-precision oncological medications.
Used as a stable reagent for in-vitro cancer research. Also, it serves as a critical marker for mitotic arrest in laboratory analysis.
| Parameter | Specification Standard |
|---|---|
| Product Name | Vinblastine sulfate |
| Grade | Pharmaceutical Grade (USP/EP) |
| Category | Oncology APIs & Vinca Alkaloids |
| CAS Number | 143-67-9 |